MORGAN STANLEY

Position in ELOX — Eloxx Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY

Position in ELOX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$21,430

+$21,430 QoQ

Shares Held

1,544

+1854.4% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 22 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. ELOX ranks #396 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,430	1,544	+1854.4%	Shares	Defined	2026-08-13
2023-09-30	—	79	0.0%	Shares	Defined	2023-11-15
2023-06-30	—	79	0.0%	Shares	Defined	2023-08-14
2023-03-31	—	79	-1.2%	Shares	Defined	2023-05-15
2022-12-31	—	80	-97.5%	Shares	Defined	2023-02-14
2022-09-30	—	3,176	-0.1%	Shares	Defined	2022-11-14
2022-06-30	—	3,180	-43.5%	Shares	Defined	2022-10-27
2022-03-31	—	5,632	+52.6%	Shares	Defined	2022-10-27
2021-12-31	—	3,691	+365.4%	Shares	Defined	2022-02-14
2021-09-30	—	793	-96.1%	Shares	Defined	2021-11-15
2021-06-30	—	20,161	+1074.2%	Shares	Defined	2021-08-23
2021-03-31	—	1,717	-94.7%	Shares	Defined	2021-05-17
2020-12-31	—	32,311	+1030.5%	Shares	Defined	2021-02-16
2020-09-30	—	2,858	-96.2%	Shares	Defined	2020-11-13
2020-06-30	—	74,968	+0.3%	Shares	Defined	2020-08-14
2020-03-31	—	74,740	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.